Whitehawk Therapeutics, Inc. (WHWK)
3.07
+0.05
(+1.66%)
USD |
NASDAQ |
Nov 06, 09:59
Whitehawk Therapeutics Market Cap : 175.02M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 172.17M |
| November 04, 2026 | 180.72M |
| November 03, 2026 | 176.73M |
| November 02, 2026 | 177.87M |
| October 30, 2026 | 184.71M |
| October 29, 2026 | 188.13M |
| October 28, 2026 | 197.25M |
| October 27, 2026 | 189.84M |
| October 26, 2026 | 179.01M |
| October 23, 2026 | 183.00M |
| October 22, 2026 | 185.28M |
| October 21, 2026 | 187.27M |
| October 20, 2026 | 181.86M |
| October 19, 2026 | 171.60M |
| October 16, 2026 | 164.76M |
| October 15, 2026 | 173.31M |
| October 14, 2026 | 169.32M |
| October 13, 2026 | 172.17M |
| October 12, 2026 | 192.69M |
| October 09, 2026 | 200.67M |
| October 08, 2026 | 197.82M |
| October 07, 2026 | 194.40M |
| October 06, 2026 | 205.80M |
| October 05, 2026 | 210.93M |
| October 02, 2026 | 210.93M |
| Date | Value |
|---|---|
| October 01, 2026 | 214.35M |
| September 30, 2026 | 214.35M |
| September 29, 2026 | 212.64M |
| September 28, 2026 | 214.35M |
| September 25, 2026 | 213.21M |
| September 24, 2026 | 220.05M |
| September 23, 2026 | 217.77M |
| September 22, 2026 | 230.32M |
| September 21, 2026 | 230.32M |
| September 18, 2026 | 239.44M |
| September 17, 2026 | 232.60M |
| September 16, 2026 | 230.32M |
| September 15, 2026 | 233.17M |
| September 14, 2026 | 232.03M |
| September 11, 2026 | 234.31M |
| September 10, 2026 | 232.03M |
| September 09, 2026 | 238.87M |
| September 08, 2026 | 250.27M |
| September 04, 2026 | 262.24M |
| September 03, 2026 | 263.95M |
| September 02, 2026 | 268.51M |
| September 01, 2026 | 263.95M |
| August 31, 2026 | 258.82M |
| August 28, 2026 | 263.38M |
| August 27, 2026 | 277.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 277.43M |
| Amgen, Inc. | 248.02B |
| Anika Therapeutics, Inc. | 226.84M |
| BioCryst Pharmaceuticals, Inc. | 1.925B |
| Imunon, Inc. | 4.012M |
Market Cap Related Metrics
| PEG Ratio | -0.0019 |
| Price to Book Value | 0.9568 |
| Price | 3.07 |
| Earnings Yield | -36.28% |
| PEGY Ratio | -0.0019 |